Skip to main content

Want a detailed portfolio tracker?

Cardio Diagnostics (CDIO) P/E (2023 - 2026)

Cardio Diagnostics (CDIO) P/E from Jan 3, 2023 to Jul 21, 2026. The TTM Cardio Diagnostics (CDIO) P/E is -0.50. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cardio Diagnostics (CDIO)

YearP/EChange
2026-0.50-32.14%
2025-0.74-73.32%
2024-2.76-4.17%
2023-2.88N/A

Comparison Cardio Diagnostics (CDIO) P/E with competitors

Cardio Diagnostics (CDIO) P/E is -0.50.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.34%
NBYStablecoin Development Corp0.00-100.86%
ENLVEnlivex Ltd0.07-114.97%
FGENFibroGen Inc0.24-148.05%
CHRSCoherus Biosciences Inc0.85-269.86%
FBIOFortress Biotech Inc0.95-289.98%
ORMPOramed Pharmaceuticals Inc1.50-400.89%
AGENAgenus Inc3.01-702.47%
INVAInnoviva Inc3.15-731.38%
VXRTVaxart Inc3.55-810.60%
CRMDCorMedix Inc3.63-826.35%
CVACCureVac N.V.4.45-989.95%
GLPGGalapagos NV4.86-1072.66%
SRPTSarepta Therapeutics Inc4.88-1077.31%
ABEOAbeona Therapeutics Inc5.39-1178.49%
ABUSArbutus Biopharma Corp5.60-1220.15%
ZVRAZevra Therapeutics Inc5.89-1278.52%
SPROSpero Therapeutics Inc6.23-1346.83%
CGENCompugen Ltd6.31-1363.94%
RIGLRigel Pharmaceuticals6.87-1475.67%
SLXNSilexion Therapeutics Corp7.30-1560.55%
OMEROmeros Corporation9.26-1953.44%
AUPHAurinia Pharmaceuticals Inc9.58-2018.74%
PLXProtalix BioTherapeutics Inc10.89-2280.19%
ACADAcadia Pharmaceuticals Inc11.73-2447.85%
TBPHTheravance Biopharma Inc12.26-2554.67%
ADMAAdma Biologics Inc12.42-2585.90%
HRMYHarmony Biosciences Holdings Inc13.82-2866.57%
SABSSAB Biotherapeutics Inc14.14-2929.83%
NAGENiagen Bioscience Inc14.82-3066.34%
INCYIncyte Corp15.82-3267.41%
REGNRegeneron Pharmaceuticals Inc15.86-3274.24%
PBYIPuma Biotechnology Inc17.32-3566.32%
CPRXCatalyst Pharmaceuticals Inc17.44-3591.06%
EXELExelixis Inc17.54-3610.82%
TGTXTG Therapeutics Inc18.97-3896.69%
MDXGMimedx Group Inc20.55-4214.27%
XOMAXOMA Royalty Corp22.87-4679.25%
ARGXArgen X SE24.30-4964.19%
CTMXCytomX Therapeutics Inc24.82-5068.91%
XOMAOXOMA Royalty Corp25.34-5173.75%
HALOHalozyme Therapeutics Inc25.62-5229.58%
XOMAPXOMA Royalty Corp25.67-5238.87%
VRTXVertex Pharmaceuticals Inc27.99-5704.23%
RPRXRoyalty Pharma plc - Class A28.69-5842.92%
SLNOSoleno Therapeutics Inc29.02-5908.54%
ASNDAscendis Pharma A/S30.09-6122.79%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7689.56%
APLSApellis Pharmaceuticals Inc39.02-7911.61%
BMRNBiomarin Pharmaceutical Inc42.21-8550.34%
KRYSKrystal Biotech Inc45.34-9177.25%
ONCBeiGene Ltd69.54-14021.22%
PHARPharming Group N.V.75.03-15119.28%
TECHBio-Techne Corp101.96-20510.93%
VCELVericel Corp109.92-22105.03%
ALNYAlnylam Pharmaceuticals Inc117.96-23715.30%
GMABGenmab140.29-28184.65%
TLXTelix Pharmaceuticals Ltd162.15-32561.19%
CORTCorcept Therapeutics Inc212.86-42711.70%